Drug Testing Locations - Parksley, VA

Drug Testing in Parksley, VA

Parksley, Virginia Statistics

Parksley, located in Accomack County, reported a 15% increase in opioid overdoses in 2022.

In Parksley, VA, drug-related arrests accounted for 25% of all local arrests in 2022.

Between 2020 and 2022, drug abuse cases in Parksley, VA, increased by 10%.

Parksley, in Accomack County, saw a 5% rise in hospitalizations due to drug overdoses in 2021.

In Parksley, VA, youth drug use cases decreased by 8% in 2022-2023.

Accomack County, which includes Parksley, reported a significant surge in methamphetamine cases in early 2023.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Parksley, VA & Drug Testing Policies

Employers in Parksley, VA, are increasingly adopting comprehensive drug testing policies to ensure a safe and productive workplace. Many businesses have implemented random drug testing as a deterrent against drug use. This approach is in line with the recommendations from the U.S. Department of Labor.

Local companies are also taking advantage of resources provided by the Occupational Safety and Health Administration (OSHA) to maintain workplace safety. Employers seek to balance privacy with safety concerns, ensuring policies comply with local and federal regulations.

Government Efforts with Drug Problems in Parksley, VA

The government of Accomack County, including Parksley, VA, has initiated several programs to tackle drug abuse. An active community outreach program increases awareness and provides resources. State efforts are supported by organizations such as the Virginia Department of Behavioral Health and Developmental Services.

The federal government supports local initiatives through grants and resources. The Drug Enforcement Administration (DEA) collaborates with local law enforcement to reduce the drug supply chain. A focus on opioid crisis intervention remains a priority in Parksley and surrounding areas.

Local Drug Busts & News in Parksley, VA

Parksley, VA, witnessed notable drug busts recently, reflecting its ongoing struggle with drug-related issues. In May 2023, local law enforcement conducted a significant sweep that resulted in multiple arrests and the seizure of illegal substances.

Authorities in Parksley continue to address drug trafficking networks that operate within Accomack County. Community awareness initiatives are coupled with law enforcement efforts to curb drug distribution and consumption.

Regular community meetings are held in Parksley where residents can voice their concerns and collaborate with police to develop solutions to drug-related challenges. These efforts aim to foster a safer environment for all residents.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Parksley, VA. Trusted by employers nationwide for accurate results and exceptional service.

Virginia DOT/Non DOT Physicals

Virginia Vision Tests

Virginia Audiograms

Virginia Respirator Fit Tests

Virginia Lift Tests

Virginia Background Checks

Clinical Testing Services

TB Testing in VA

Diabetes Testing in VA

Infectious Disease Testing in VA

Sickle Cell Anemia Testing in VA

Women/Men's Health Testing in VA

Resources & Citations

Virginia Association of Drug and Alcohol Counseling

Virginia Coalition on o-drug Prevention and Outreach

Virginia Hospital & Healthcare Association

Prevent Substance Abuse Coalition

Community Services Board of Accomack County

Virginia Department of Health

National Alliance on Mental Illness Virginia

Virginia Legal Aid Society

Alcoholics Anonymous Virginia

Substance Abuse and Mental Health Services Administration

Drug Testing Near Parksley, VA

Nelsonia, VA

Accomac, VA

Bayside, VA

Bloxom, VA

Gargatha, VA

Greenbush, VA

Metompkin, VA

Pastoria, VA

Chase Crossing, VA

Lee Mont, VA

Whitesville, VA

Frequently Asked Questions

Customer Reviews